J0517 – Injection, benralizumab, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0517
- Long description
- Injection, benralizumab, 1 mg
- Short description
- Inj., benralizumab, 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2019
- Last change
- January 1, 2019 – No change
Frequently asked questions
What is HCPCS code J0517?
J0517 is a HCPCS Level II code for injection, benralizumab, 1 mg.
Does Medicare cover J0517?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0475 – Injection, baclofen, 10 mg
- J0476 – Injection, baclofen, 50 mcg for intrathecal trial
- J0480 – Injection, basiliximab, 20 mg
- J0485 – Injection, belatacept, 1 mg
- J0490 – Injection, belimumab, 10 mg
- J0491 – Injection, anifrolumab-fnia, 1 mg
- J0500 – Injection, dicyclomine hcl, up to 20 mg
- J0515 – Injection, benztropine mesylate, per 1 mg
- J0520 – Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
- J0525 – Injection, cefotetan disodium, 10 mg
- J0528 – Injection, fosfomycin disodium, 20 mg
- J0558 – Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
- J0561 – Injection, penicillin g benzathine, 100,000 units
- J0565 – Injection, bezlotoxumab, 10 mg
- J0567 – Injection, cerliponase alfa, 1 mg
- J0570 – Buprenorphine implant, 74.2 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.